Company / Current Liabilities
iBio, Inc. Current Liabilities History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$6.1M
FY2025
5-year range
$6.1M / $30.4M
FY2021-FY2025
Trend
-72.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities has fluctuated over the past 10 years, ranging from $2M in FY2017 to $30M in FY2022.
Based on SEC 10-K filings.
$6M in FY2025 with a 5-year CAGR of +3.1%.
Improved from $22M to $6M over the past 2 years.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- -41.5%
- 5-Year CAGR
- +3.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +3.1%, indicating consistent growth.
- In FY2025, current liabilities decreased 72.4% year-over-year.
- Peak current liabilities was recorded in FY2022.
- Lowest current liabilities in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -1.36 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.1M | -72.4% |
| FY2024 | $22.1M | +2.4% |
| FY2023 | $21.6M | -29.1% |
| FY2022 | $30.4M | +358.0% |
| FY2021 | $6.6M | +26.9% |
| FY2020 | $5.2M | +51.4% |
| FY2019 | $3.5M | +69.9% |
| FY2018 | $2.0M | +1.1% |
| FY2017 | $2.0M | -12.1% |
| FY2016 | $2.3M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026